Maximally tolerated dose (MTD), determined according to dose-limiting toxicities (DLTs) graded using Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0) Up to 24 weeks [clinicaltrials_resource:96a85e705f8124fae3b9b3e26c40efc1]
Simple summary statistics will be supplemented with Kaplan-Meier survival estimates and related confidence intervals.The effect of dose and ancillary dichotomized covariates such as gender or age (<50 years versus 50+ years) will be explored using logrank testing involving one covariate at a time.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Maximally tolerated dose (MTD), determined according to dose-limiting toxicities (DLTs) graded using Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0) Up to 24 weeks [clinicaltrials_resource:96a85e705f8124fae3b9b3e26c40efc1]
Simple summary statistics will be supplemented with Kaplan-Meier survival estimates and related confidence intervals.The effect of dose and ancillary dichotomized covariates such as gender or age (<50 years versus 50+ years) will be explored using logrank testing involving one covariate at a time.
Bio2RDF identifier
96a85e705f8124fae3b9b3e26c40efc1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:96a85e705f8124fae3b9b3e26c40efc1
measure [clinicaltrials_vocabulary:measure]
Maximally tolerated dose (MTD) ...... vents version 3.0 (CTCAE v3.0)
time frame [clinicaltrials_vocabulary:time-frame]
Up to 24 weeks
description
Simple summary statistics will ...... lving one covariate at a time.
identifier
clinicaltrials_resource:96a85e705f8124fae3b9b3e26c40efc1
title
Maximally tolerated dose (MTD) ...... .0 (CTCAE v3.0) Up to 24 weeks
@en
type
label
Maximally tolerated dose (MTD) ...... 85e705f8124fae3b9b3e26c40efc1]
@en